Synthetic Biology to Engineer Bacteriophage Genomes.
BRED
Bacteriophage
Bacteriophage engineering
YAC
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
8
12
2023
Statut:
ppublish
Résumé
Recent advances in the synthetic biology field have enabled the development of new molecular biology techniques used to build specialized bacteriophages with new functionalities. Bacteriophages have been engineered toward a wide range of applications, including pathogen control and detection, targeted drug delivery, or even assembly of new materials.In this chapter, two strategies that have been successfully used to genetically engineer bacteriophage genomes will be addressed: the bacteriophage recombineering of electroporated DNA (BRED) and the yeast-based phage-engineering platform.
Identifiants
pubmed: 38066375
doi: 10.1007/978-1-0716-3523-0_17
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
261-277Informations de copyright
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Clark JR, March JB (2006) Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol 24:212–218
doi: 10.1016/j.tibtech.2006.03.003
pubmed: 16567009
Kutter E, De Vos D, Gvasalia G et al (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11:69–86
doi: 10.2174/138920110790725401
pubmed: 20214609
Endersen L, O’Mahony J, Hill C et al (2014) Phage therapy in the food industry. Annu Rev Food Sci Technol 5:327–349
doi: 10.1146/annurev-food-030713-092415
pubmed: 24422588
Jones JB, Jackson LE, Balogh B et al (2007) Bacteriophages for plant disease control. Annu Rev Phytopathol 45:245–262
doi: 10.1146/annurev.phyto.45.062806.094411
pubmed: 17386003
Monk AB, Rees CD, Barrow P et al (2010) Bacteriophage applications: where are we now? Lett Appl Microbiol 51:363–369
doi: 10.1111/j.1472-765X.2010.02916.x
pubmed: 20796209
Kilcher S, Loessner MJ (2019) Engineering bacteriophages as versatile biologics. Trends Microbiol 27:355–367
doi: 10.1016/j.tim.2018.09.006
pubmed: 30322741
Schmelcher M, Loessner MJ (2014) Application of bacteriophages for detection of foodborne pathogens. Bacteriophage 4:e28137
doi: 10.4161/bact.28137
pubmed: 24533229
pmcid: 3919822
Lu TK, Bowers J, Koeris MS (2013) Advancing bacteriophage-based microbial diagnostics with synthetic biology. Trends Biotechnol 31:325–327
doi: 10.1016/j.tibtech.2013.03.009
pubmed: 23608522
Yacoby I, Bar H, Benhar I (2007) Targeted drug-carrying bacteriophages as antibacterial nanomedicines. Antimicrob Agents Chemother 51:2156–2163
doi: 10.1128/AAC.00163-07
pubmed: 17404004
pmcid: 1891362
Ju Z, Sun W (2017) Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles. Drug Deliv 24:1898
doi: 10.1080/10717544.2017.1410259
pubmed: 29191048
pmcid: 8241185
Pires DP, Cleto S, Sillankorva S et al (2016) Genetically engineered phages: a review of advances over the last decade. Microbiol Mol Biol Rev 80:523–543
doi: 10.1128/MMBR.00069-15
pubmed: 27250768
pmcid: 4981678
Mahler M, Costa AR, van Beljouw SPB et al (2022) Approaches for bacteriophage genome engineering. Trends Biotechnol 41:669
doi: 10.1016/j.tibtech.2022.08.008
pubmed: 36117025
Marinelli LJ, Piuri M, Swigonová Z et al (2008) BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes. PLoS One 3:e3957
doi: 10.1371/journal.pone.0003957
pubmed: 19088849
pmcid: 2597740
Marinelli LJ, Hatfull GF, Piuri M (2012) Recombineering: a powerful tool for modification of bacteriophage genomes. Bacteriophage 2:5–14
doi: 10.4161/bact.18778
pubmed: 22666652
pmcid: 3357384
Fehér T, Karcagi I, Blattner FR et al (2012) Bacteriophage recombineering in the lytic state using the lambda red recombinases. Microb Biotechnol 5:466–476
doi: 10.1111/j.1751-7915.2011.00292.x
pubmed: 21910851
pmcid: 3815324
Nobrega FL, Costa AR, Santos JF et al (2016) Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine. Sci Rep 6:1–12
doi: 10.1038/srep39235
Ramirez-Chamorro L, Boulanger P, Rossier O (2021) Strategies for bacteriophage T5 mutagenesis: expanding the toolbox for phage genome engineering. Front Microbiol 12:667332
doi: 10.3389/fmicb.2021.667332
pubmed: 33981295
pmcid: 8108384
Hupfeld M, Trasanidou D, Ramazzini L et al (2018) A functional type II-A CRISPR–Cas system from Listeria enables efficient genome editing of large non-integrating bacteriophage. Nucleic Acids Res 46:6920
doi: 10.1093/nar/gky544
pubmed: 30053228
pmcid: 6061871
Møller-Olsen C, Ho SFS, Shukla RD et al (2018) Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells. Sci Reports 81(8):1–18
Bari SMN, Walker FC, Cater K et al (2017) Strategies for editing virulent staphylococcal phages using CRISPR-Cas10. ACS Synth Biol 6:2316–2325
doi: 10.1021/acssynbio.7b00240
pubmed: 28885820
Box AM, McGuffie MJ, O’Hara BJ et al (2016) Functional analysis of bacteriophage immunity through a type I-E CRISPR-Cas system in Vibrio cholerae and its application in bacteriophage genome engineering. J Bacteriol 198:578–590
doi: 10.1128/JB.00747-15
pubmed: 26598368
pmcid: 4719448
Guan J, Bosch AO, Mendoza SD et al (2022) RNA targeting with CRISPR-Cas13a facilitates bacteriophage genome engineering. 2022.02.14.480438
Adler BA, Hessler T, Cress BF et al (2022) Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing. Nat Microbiol 712(7):1967–1979
doi: 10.1038/s41564-022-01258-x
Ando H, Lemire S, Pires DP et al (2015) Engineering modular viral scaffolds for targeted bacterial population editing. Cell Syst 1:187–196
doi: 10.1016/j.cels.2015.08.013
pubmed: 26973885
pmcid: 4785837
Pires DP, Monteiro R, Mil-Homens D et al (2021) Designing P. aeruginosa synthetic phages with reduced genomes. Sci Rep 11:2164
doi: 10.1038/s41598-021-81580-2
pubmed: 33495501
pmcid: 7835345
Latka A, Lemire S, Grimon D et al (2021) Engineering the modular receptor-binding proteins of Klebsiella phages switches their capsule serotype specificity. MBio 12:e00455-21
doi: 10.1128/mBio.00455-21
pubmed: 33947754
pmcid: 8262889
Kilcher S, Studer P, Muessner C et al (2018) Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria. Proc Natl Acad Sci U S A 115:567–572
doi: 10.1073/pnas.1714658115
pubmed: 29298913
pmcid: 5776983
Dunne M, Rupf B, Tala M et al (2019) Reprogramming bacteriophage host range through structure-guided design of chimeric receptor binding proteins. Cell Rep 29:1336–1350.e4
doi: 10.1016/j.celrep.2019.09.062
pubmed: 31665644
Shin J, Jardine P, Noireaux V (2012) Genome replication, synthesis, and assembly of the bacteriophage T7 in a single cell-free reaction. ACS Synth Biol 1:408–413
doi: 10.1021/sb300049p
pubmed: 23651338
Garamella J, Marshall R, Rustad M et al (2016) The All E. coli TX-TL toolbox 2.0: a platform for cell-free synthetic biology. ACS Synth Biol 5:344–355
doi: 10.1021/acssynbio.5b00296
pubmed: 26818434
Rustad M, Eastlund A, Jardine P et al (2018) Cell-free TXTL synthesis of infectious bacteriophage T4 in a single test tube reaction. Synth Biol 3:ysy002
doi: 10.1093/synbio/ysy002
Emslander Q, Vogele K, Braun P et al (2022) Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria. Cell Chem Biol 29:1434–1445.e7
doi: 10.1016/j.chembiol.2022.06.003
pubmed: 35820417
Liang J, Zhang H, Tan YL et al (2022) Directed evolution of replication-competent double-stranded DNA bacteriophage toward new host specificity. ACS Synth Biol 11:634–643
doi: 10.1021/acssynbio.1c00319
pubmed: 35090114
Murphy KC (2007) The λ gam protein inhibits RecBCD binding to dsDNA ends. J Mol Biol 371:19–24
doi: 10.1016/j.jmb.2007.05.085
pubmed: 17583735
Court R, Cook N, Saikrishnan K et al (2007) The crystal structure of λ-gam protein suggests a model for RecBCD inhibition. J Mol Biol 371:25–33
doi: 10.1016/j.jmb.2007.05.037
pubmed: 17544443
Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645
doi: 10.1073/pnas.120163297
pubmed: 10829079
pmcid: 18686
Hanahan D (1983) Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166:557–580
doi: 10.1016/S0022-2836(83)80284-8
pubmed: 6345791
Xu K, Hua J, Roberts KJ et al (2012) Production of recombineering substrates with standard-size PCR primers. FEMS Microbiol Lett 337:97
doi: 10.1111/1574-6968.12016
pubmed: 23003673